Moleculin Biotech (MBRX) Tax Rate (2019 - 2020)
Moleculin Biotech (MBRX) posted quarterly Tax Rate of 5.24% for Q3 2019.
Moleculin Biotech (MBRX) Tax Rate (2019 - 2020) Analysis & Trends
Moleculin Biotech's Tax Rate history runs 1 years deep, the most recent figure standing at 5.24% for Q3 2019.
- In Q3 2019, Tax Rate changed N/A year-over-year to 5.24%; the TTM figure through Dec 2020 stood at 1.41% (up 44.0% YoY), while the FY2019 annual figure was 1.7%, changed N/A from the prior year.
- Tax Rate for Q3 2019 stood at 5.24%.
- The five-year high for Tax Rate was 5.24% in Q3 2019, with the low at 5.24% in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 10.91% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -1.96% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 24.15% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 7.49% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 34.12% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -16.71% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Moleculin Biotech | 3.37 Mn | 3.37 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -138.12% |
| Dec 31, 2020 | -138.12% |
| Dec 31, 2020 | -138.12% |
| Dec 31, 2019 | -79.06% |
| Dec 31, 2019 | -79.06% |
| Dec 31, 2019 | -79.06% |
| Sep 30, 2019 | 5.24% |
| Sep 30, 2019 | 5.24% |
| Sep 30, 2019 | 5.24% |